Seeking AlphaCodex · 实盘不做把握 5/10
北京时间·🕒 发布 18:54:02时区推断·⟳ 抓取 18:56:28·⚡ 决策 07-28 18:57:49 +1m21s·91.0 天前
Centene二季度业绩大幅超预期并上调全年指引
Centene（CNC.US）二季度收入536亿美元、调整EPS 2.51美元，均明显高于一致预期，全年调整EPS指引从大于3.40美元上调至大于4.80美元。
📄 原文Seeking Alpha↗ 原文
Centene spikes on strong Q2 beat, guidance hike
Cenetene (CNC) shares gained in the premarket on Tuesday after the managed care firm raised its full-year earnings outl…
不做 Centene（CNC.US）
财报利好方向明确，但属于排期财报且盘前已跳涨，指引上调含约0.50美元一次性项目；缺少真实盘前价与开盘承接确认，不追高做多。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
消息传播链
- Centene正式发布二季度业绩并上调2026年收入和调整EPS指引。
- Seeking Alpha报道CNC盘前上涨，说明消息已进入盘前交易定价阶段。市场反应:报道称CNC盘前上涨。
关键理由
- Centene（CNC.US）二季度收入536亿美元、调整EPS 2.51美元，均明显高于一致预期，全年调整EPS指引从大于3.40美元上调至大于4.80美元。
- 利润改善主要来自HBR下降，商业业务HBR从90.6%降至79.2%，但公司披露全年指引上调中约0.50美元来自Medicare和Commercial的一次性项目。
- 这是排期财报前披露，且盘前新闻已显示股价跳涨，短线追多需要真实盘前价格和开盘承接确认。
主要风险
- 财报类事件在美股盘前已快速重定价，开盘后存在高开低走风险。
- 上调指引中包含约0.50美元非经常性项目，若市场剔除一次性贡献，估值重定价幅度会被压缩。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-07-28 · 影响 weakens
未发现足以推翻本次正面财报方向的新增利空，但一次性项目贡献和Medicaid会员同比下降削弱追多质量。
检索:Centene recent bearish risks Medicaid Medicare Advantage 2026 guidance July 2026 原文 ↗
原文全文
展开原文 · 1,323 字
Cenetene (CNC) shares gained in the premarket on Tuesday after the managed care firm raised its full-year earnings outlook above consensus with its Q2 2026 results, which well surpassed expectations, thanks mainly to lower medical costs.
The Saint Louis, Missouri-based firm reported $53.6B in revenue for the quarter, topping consensus estimates by $6.1B with nearly 10% YoY growth even as members enrolled in its Medicaid segment fell ~6% YoY to ~12.1M.
Meanwhile, its adjusted earnings per share rose to $2.51 from a loss of $0.16 per share in Q2 2025, exceeding Street forecasts by $1.43 amid declining medical costs.
The health benefits ratio in its commercial business dropped to 79.2% from 90.6% in the prior-year period, and the company’s overall HBR fell to 89.6% from 93.6% last year, mainly due to a lower Marketplace HBR driven by improved pricing and risk transfer.
"Our second quarter results and improved full-year outlook represent meaningful milestones on our path to restoring profitability and increasing shareholder value," CEO Sarah London remarked.
Looking ahead for the full year, the company raised its revenue guidance to $193.5B - $197.5B, up $6B from the prior forecast, and adjusted guidance to more than $4.80 from $3.40 previously, compared to $190.3B and $3.52 in the consensus, respectively.
The Saint Louis, Missouri-based firm reported $53.6B in revenue for the quarter, topping consensus estimates by $6.1B with nearly 10% YoY growth even as members enrolled in its Medicaid segment fell ~6% YoY to ~12.1M.
Meanwhile, its adjusted earnings per share rose to $2.51 from a loss of $0.16 per share in Q2 2025, exceeding Street forecasts by $1.43 amid declining medical costs.
The health benefits ratio in its commercial business dropped to 79.2% from 90.6% in the prior-year period, and the company’s overall HBR fell to 89.6% from 93.6% last year, mainly due to a lower Marketplace HBR driven by improved pricing and risk transfer.
"Our second quarter results and improved full-year outlook represent meaningful milestones on our path to restoring profitability and increasing shareholder value," CEO Sarah London remarked.
Looking ahead for the full year, the company raised its revenue guidance to $193.5B - $197.5B, up $6B from the prior forecast, and adjusted guidance to more than $4.80 from $3.40 previously, compared to $190.3B and $3.52 in the consensus, respectively.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。